Detalles de la búsqueda
1.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
N Engl J Med
; 385(23): 2150-2160, 2021 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34449183
2.
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study.
Thromb J
; 21(1): 124, 2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38098072
3.
Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic Stroke.
JAMA
; 329(23): 2038-2049, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338878
4.
Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patientsã- A Subanalysis of the ENVISAGE-TAVI AF Trial.
Circ J
; 86(11): 1756-1763, 2022 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35965066
5.
Thromboembolic and bleeding risks in edoxaban patients with pacemaker and cardiac monitoring procedures: Outcomes of the Global EMIT program.
Pacing Clin Electrophysiol
; 45(1): 83-91, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34662445
6.
Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
JAMA
; 327(8): 760-771, 2022 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35143601
7.
Edoxaban or Vitamin K Antagonist for Atrial Fibrillation after TAVR. Reply.
N Engl J Med
; 386(8): 804, 2022 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35196442
8.
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial.
Am Heart J
; 205: 63-69, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30172099
9.
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study).
Eur Heart J
; 41(38): 3715-3728, 2020 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31511862
10.
Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation Patients From Asiaã- One-Year Data From the Global ETNA-AF Program.
Circ Rep
; 6(3): 86-93, 2024 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38464984
11.
Outcomes after TAVI in patients with atrial fibrillation and a history of recent PCI: Results from the ENVISAGE-TAVI AF trial.
Clin Res Cardiol
; 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294497
12.
Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry.
Sci Rep
; 14(1): 2778, 2024 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38307927
13.
Wound cleaning and wound healing: a concise review.
Adv Skin Wound Care
; 26(4): 160-3, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23507692
14.
Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF Program.
J Clin Med
; 12(5)2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36902656
15.
Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF Trial.
Am J Cardiol
; 209: 212-219, 2023 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37848174
16.
Predictive Factors and Clinical Events Associated with Edoxaban Interruption and Heparin Bridging Strategy: EMIT-AF/VTE.
Clin Appl Thromb Hemost
; 29: 10760296231200223, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37697813
17.
Edoxaban use in the context of dental procedures: analysis from the EMIT-AF/VTE database.
BDJ Open
; 9(1): 38, 2023 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37580338
18.
Predictors of All-Cause Mortality After Successful Transcatheter Aortic Valve Implantation in Patients With Atrial Fibrillation.
Am J Cardiol
; 207: 150-158, 2023 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37741105
19.
The 'all comer' Coroflex Please drug-eluting stent registry in Europe and Asia - an overall and transcontinental assessment of the 10-month major adverse cardiac events.
Indian Heart J
; 64(5): 453-61, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23102382
20.
Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program.
J Clin Med
; 10(4)2021 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33546442